JANL Form 4: Director Karen Miller Ryan records 2,500-share acquisition
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Karen Miller Ryan, a director of JANEL CORP (JANL), reported a transaction dated 10/01/2025 involving 2,500 derivative securities described as a Stock Option (Right to Buy) with an exercise price of $36.01. The Form 4 shows the transaction code A (acquisition) for 2,500 underlying shares of Common Stock, and reports 2,500 shares beneficially owned following the reported transaction, held directly. The Form lists a Date Exercisable of 12/31/2028 and an Expiration Date of 09/30/2035.
Positive
- Director acquired 2,500 shares (via option exercise) showing insider purchase activity
- Exercise price documented at $36.01, transaction clearly disclosed on Form 4
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Miller Ryan Karen
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,500 shares (Direct)
Footnotes (1)
FAQ
What did Karen Miller Ryan report on the Form 4 for JANL?
The Form 4 reports an acquisition on 10/01/2025 of 2,500 underlying shares via a Stock Option with an exercise price of $36.01.
What are the exercisability and expiration dates shown on the Form 4?
The Form 4 lists a Date Exercisable of 12/31/2028 and an Expiration Date of 09/30/2035.
What transaction code was used and what does it indicate?
The filing uses transaction code A, which the Form identifies as an acquisition.
Which issuer and ticker are associated with this Form 4?
The issuer is JANEL CORP with ticker JANL.